Stay updated on Abemaciclib and Nivolumab for HCC Clinical Trial

Sign up to get notified when there's something new on the Abemaciclib and Nivolumab for HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abemaciclib and Nivolumab for HCC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Recruitment status on the study page now indicates no participants are being sought. The page also introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a new revision tag (Revision: v3.6.0), with a minor heading formatting adjustment around Intervention/Treatment.
    Difference
    0.6%
    Check dated 2026-06-13T23:59:31.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, indicating an internal platform update with no changes to the study details or visible content.
    Difference
    0.1%
    Check dated 2026-06-06T19:19:21.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a small backend or UI update to the study page.
    Difference
    0.1%
    Check dated 2026-05-16T09:17:29.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page’s footer software release/revision indicator was updated from v3.5.2 to v3.5.3, reflecting a site/UI version change without altering the study information displayed.
    Difference
    0.1%
    Check dated 2026-04-24T22:44:30.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T14:18:03.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Hepatocellular carcinoma is now listed as the study condition and a Genetics and Rare Diseases Information Center resource link was added under Resources; the page revision updated from 3.4.3 to 3.5.0.
    Difference
    0.2%
    Check dated 2026-03-19T23:48:35.000Z thumbnail image

Stay in the know with updates to Abemaciclib and Nivolumab for HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abemaciclib and Nivolumab for HCC Clinical Trial page.